Rafal Gorcazniak

MMD, FSHD, OPMD, and some forms of EDMD and ALS, might benefit from new strategy

posted on April 18, 2009 - 9:00pm

A new gene therapy approach to "silencing" disease-causing genetic information has been developed by researchers at Rutgers University in Piscataway, N.J., and Integrated DNA Technologies in Coralville, Ia.